Incyte

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.

About INCY

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. 

CEO
William J. Meury
CEOWilliam J. Meury
Employees
2,844
Employees2,844
Headquarters
Wilmington, Delaware
HeadquartersWilmington, Delaware
Founded
1991
Founded1991
Employees
2,844
Employees2,844

INCY Key Statistics

Market cap
19.31B
Market cap19.31B
Price-Earnings ratio
13.52
Price-Earnings ratio13.52
Dividend yield
Dividend yield
Average volume
1.31M
Average volume1.31M
High today
$98.40
High today$98.40
Low today
$96.00
Low today$96.00
Open price
$98.40
Open price$98.40
Volume
512.34K
Volume512.34K
52 Week high
$112.29
52 Week high$112.29
52 Week low
$63.51
52 Week low$63.51

Stock Snapshot

The current Incyte(INCY) stock price is $96.66, with a market capitalization of 19.31B. The stock trades at a price-to-earnings (P/E) ratio of 13.52.

On 2026-05-20, Incyte(INCY) stock traded between a low of $96.00 and a high of $98.40. Shares are currently priced at $96.66, which is +0.7% above the low and -1.8% below the high.

The Incyte(INCY)'s current trading volume is 512.34K, compared to an average daily volume of 1.31M.

During the past year, Incyte(INCY) stock moved between $63.51 at its lowest and $112.29 at its peak.

During the past year, Incyte(INCY) stock moved between $63.51 at its lowest and $112.29 at its peak.

INCY News

TipRanks 7h
Incyte, Genesis Molecular AI announce expansion of collaboration

Incyte (INCY) and Genesis Molecular AI announced a significant expansion of their strategic collaboration building and deploying AI to accelerate the discovery...

Barchart 1d
Incyte Stock: Analyst Estimates & Ratings - Barchart.com

...

Incyte Stock: Analyst Estimates & Ratings - Barchart.com

Analyst ratings

53%

of 30 ratings
Buy
36.7%
Hold
53.3%
Sell
10%

People also own

Based on the portfolios of people who own INCY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.